Gene Therapy Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Gene Therapy Market size was valued at US$ 3.75 Billion in 2025 and is projected to reach US$ 19.75 Billion by 2033, growing at a CAGR of 23.08% during 2026–2033, driven by rare-disease treatment advances, genetic medicine innovation, vector engineering, clinical expansion, and reimbursement opportunities.

Report Coverage

Product: Zolgensma, Luxturna, Roctavian, Others
Vector Type: Viral Vectors, Non-Viral Vectors
Indication: Genetic Disorders, Ophthalmology, Hematology, Others
End User: Hospitals & Clinics, Specialty Clinics, Others

US$ 3.75 Bn Market size in 2025

US$ 19.75 Bn Market Size by 2033

23.08% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00038135

Last Updated: 2026-08-20

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Gene Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Gene Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Gene Therapy Market Global Analysis

6.2 Gene Therapy Market Revenue 2022-2033 (US$ Billion)

6.3 Gene Therapy Market Forecast Analysis

7. Gene Therapy Market Analysis – by Product

7.1 Zolgensma

7.1.1 Overview
7.1.2 Zolgensma: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Luxturna

7.2.1 Overview
7.2.2 Luxturna: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.3 Roctavian

7.3.1 Overview
7.3.2 Roctavian: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.4 Others

7.4.1 Overview
7.4.2 Others: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Gene Therapy Market Analysis – by Vector Type

8.1 Viral Vectors

8.1.1 Overview
8.1.2 Viral Vectors: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Non-Viral Vectors

8.2.1 Overview
8.2.2 Non-Viral Vectors: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Gene Therapy Market Analysis – by Indication

9.1 Genetic Disorders

9.1.1 Overview
9.1.2 Genetic Disorders: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Ophthalmology

9.2.1 Overview
9.2.2 Ophthalmology: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.3 Hematology

9.3.1 Overview
9.3.2 Hematology: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.4 Others

9.4.1 Overview
9.4.2 Others: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Gene Therapy Market Analysis – by End User

10.1 Hospitals & Clinics

10.1.1 Overview
10.1.2 Hospitals & Clinics: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.2 Specialty Clinics

10.2.1 Overview
10.2.2 Specialty Clinics: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.3 Others

10.3.1 Overview
10.3.2 Others: Gene Therapy Market – Revenue and Forecast, 2022-2033 (US$ Billion)

11. Gene Therapy Market – Geographic Analysis

11.1 Overview

11.2 North America

11.2.1 Gene Therapy Market Breakdown, by Key Country, 2026 and 2033 (%)
11.2.1.1 Gene Therapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.1.1 US: Gene Therapy Market Breakdown, by Product
11.2.1.1.2 US: Gene Therapy Market Breakdown, by Vector Type
11.2.1.1.3 US: Gene Therapy Market Breakdown, by Indication
11.2.1.1.4 US: Gene Therapy Market Breakdown, by End User

11.2.1.2 Canada: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.2.1 Canada: Gene Therapy Market Breakdown, by Product
11.2.1.2.2 Canada: Gene Therapy Market Breakdown, by Vector Type
11.2.1.2.3 Canada: Gene Therapy Market Breakdown, by Indication
11.2.1.2.4 Canada: Gene Therapy Market Breakdown, by End User

11.2.1.3 Mexico : Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.3.1 Mexico : Gene Therapy Market Breakdown, by Product
11.2.1.3.2 Mexico : Gene Therapy Market Breakdown, by Vector Type
11.2.1.3.3 Mexico : Gene Therapy Market Breakdown, by Indication
11.2.1.3.4 Mexico : Gene Therapy Market Breakdown, by End User

11.3 Europe

11.3.1 Gene Therapy Market Breakdown, by Key Country, 2026 and 2033 (%)
11.3.1.1 Gene Therapy Market – Revenue and Forecast Analysis – by Country
11.3.1.1 Germany: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.1.1 Germany: Gene Therapy Market Breakdown, by Product
11.3.1.1.2 Germany: Gene Therapy Market Breakdown, by Vector Type
11.3.1.1.3 Germany: Gene Therapy Market Breakdown, by Indication
11.3.1.1.4 Germany: Gene Therapy Market Breakdown, by End User

11.3.1.2 Italy: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.2.1 Italy: Gene Therapy Market Breakdown, by Product
11.3.1.2.2 Italy: Gene Therapy Market Breakdown, by Vector Type
11.3.1.2.3 Italy: Gene Therapy Market Breakdown, by Indication
11.3.1.2.4 Italy: Gene Therapy Market Breakdown, by End User

11.3.1.3 France: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.3.1 France: Gene Therapy Market Breakdown, by Product
11.3.1.3.2 France: Gene Therapy Market Breakdown, by Vector Type
11.3.1.3.3 France: Gene Therapy Market Breakdown, by Indication
11.3.1.3.4 France: Gene Therapy Market Breakdown, by End User

11.3.1.4 U.K.: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.4.1 U.K.: Gene Therapy Market Breakdown, by Product
11.3.1.4.2 U.K.: Gene Therapy Market Breakdown, by Vector Type
11.3.1.4.3 U.K.: Gene Therapy Market Breakdown, by Indication
11.3.1.4.4 U.K.: Gene Therapy Market Breakdown, by End User

11.3.1.5 Spain: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.5.1 Spain: Gene Therapy Market Breakdown, by Product
11.3.1.5.2 Spain: Gene Therapy Market Breakdown, by Vector Type
11.3.1.5.3 Spain: Gene Therapy Market Breakdown, by Indication
11.3.1.5.4 Spain: Gene Therapy Market Breakdown, by End User

11.3.1.6 Belgium: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.6.1 Belgium: Gene Therapy Market Breakdown, by Product
11.3.1.6.2 Belgium: Gene Therapy Market Breakdown, by Vector Type
11.3.1.6.3 Belgium: Gene Therapy Market Breakdown, by Indication
11.3.1.6.4 Belgium: Gene Therapy Market Breakdown, by End User

11.3.1.7 Netherlands: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.7.1 Netherlands: Gene Therapy Market Breakdown, by Product
11.3.1.7.2 Netherlands: Gene Therapy Market Breakdown, by Vector Type
11.3.1.7.3 Netherlands: Gene Therapy Market Breakdown, by Indication
11.3.1.7.4 Netherlands: Gene Therapy Market Breakdown, by End User

11.3.1.8 Luxembourg: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.8.1 Luxembourg: Gene Therapy Market Breakdown, by Product
11.3.1.8.2 Luxembourg: Gene Therapy Market Breakdown, by Vector Type
11.3.1.8.3 Luxembourg: Gene Therapy Market Breakdown, by Indication
11.3.1.8.4 Luxembourg: Gene Therapy Market Breakdown, by End User

11.3.1.9 Norway: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.9.1 Norway: Gene Therapy Market Breakdown, by Product
11.3.1.9.2 Norway: Gene Therapy Market Breakdown, by Vector Type
11.3.1.9.3 Norway: Gene Therapy Market Breakdown, by Indication
11.3.1.9.4 Norway: Gene Therapy Market Breakdown, by End User

11.3.1.10 Finland: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.10.1 Finland: Gene Therapy Market Breakdown, by Product
11.3.1.10.2 Finland: Gene Therapy Market Breakdown, by Vector Type
11.3.1.10.3 Finland: Gene Therapy Market Breakdown, by Indication
11.3.1.10.4 Finland: Gene Therapy Market Breakdown, by End User

11.3.1.11 Denmark: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.11.1 Denmark: Gene Therapy Market Breakdown, by Product
11.3.1.11.2 Denmark: Gene Therapy Market Breakdown, by Vector Type
11.3.1.11.3 Denmark: Gene Therapy Market Breakdown, by Indication
11.3.1.11.4 Denmark: Gene Therapy Market Breakdown, by End User

11.3.1.12 Sweden: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.12.1 Sweden: Gene Therapy Market Breakdown, by Product
11.3.1.12.2 Sweden: Gene Therapy Market Breakdown, by Vector Type
11.3.1.12.3 Sweden: Gene Therapy Market Breakdown, by Indication
11.3.1.12.4 Sweden: Gene Therapy Market Breakdown, by End User

11.3.1.13 Switzerland: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.13.1 Switzerland: Gene Therapy Market Breakdown, by Product
11.3.1.13.2 Switzerland: Gene Therapy Market Breakdown, by Vector Type
11.3.1.13.3 Switzerland: Gene Therapy Market Breakdown, by Indication
11.3.1.13.4 Switzerland: Gene Therapy Market Breakdown, by End User

11.3.1.14 Austria: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.14.1 Austria: Gene Therapy Market Breakdown, by Product
11.3.1.14.2 Austria: Gene Therapy Market Breakdown, by Vector Type
11.3.1.14.3 Austria: Gene Therapy Market Breakdown, by Indication
11.3.1.14.4 Austria: Gene Therapy Market Breakdown, by End User

11.3.1.15 Greece: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.15.1 Greece: Gene Therapy Market Breakdown, by Product
11.3.1.15.2 Greece: Gene Therapy Market Breakdown, by Vector Type
11.3.1.15.3 Greece: Gene Therapy Market Breakdown, by Indication
11.3.1.15.4 Greece: Gene Therapy Market Breakdown, by End User

11.3.1.16 Portugal: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.16.1 Portugal: Gene Therapy Market Breakdown, by Product
11.3.1.16.2 Portugal: Gene Therapy Market Breakdown, by Vector Type
11.3.1.16.3 Portugal: Gene Therapy Market Breakdown, by Indication
11.3.1.16.4 Portugal: Gene Therapy Market Breakdown, by End User

11.3.1.17 Russia: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.17.1 Russia: Gene Therapy Market Breakdown, by Product
11.3.1.17.2 Russia: Gene Therapy Market Breakdown, by Vector Type
11.3.1.17.3 Russia: Gene Therapy Market Breakdown, by Indication
11.3.1.17.4 Russia: Gene Therapy Market Breakdown, by End User

11.3.1.18 Poland: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.18.1 Poland: Gene Therapy Market Breakdown, by Product
11.3.1.18.2 Poland: Gene Therapy Market Breakdown, by Vector Type
11.3.1.18.3 Poland: Gene Therapy Market Breakdown, by Indication
11.3.1.18.4 Poland: Gene Therapy Market Breakdown, by End User

11.3.1.19 Romania: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.19.1 Romania: Gene Therapy Market Breakdown, by Product
11.3.1.19.2 Romania: Gene Therapy Market Breakdown, by Vector Type
11.3.1.19.3 Romania: Gene Therapy Market Breakdown, by Indication
11.3.1.19.4 Romania: Gene Therapy Market Breakdown, by End User

11.3.1.20 Czech Republic: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.20.1 Czech Republic: Gene Therapy Market Breakdown, by Product
11.3.1.20.2 Czech Republic: Gene Therapy Market Breakdown, by Vector Type
11.3.1.20.3 Czech Republic: Gene Therapy Market Breakdown, by Indication
11.3.1.20.4 Czech Republic: Gene Therapy Market Breakdown, by End User

11.3.1.21 Ukraine: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.21.1 Ukraine: Gene Therapy Market Breakdown, by Product
11.3.1.21.2 Ukraine: Gene Therapy Market Breakdown, by Vector Type
11.3.1.21.3 Ukraine: Gene Therapy Market Breakdown, by Indication
11.3.1.21.4 Ukraine: Gene Therapy Market Breakdown, by End User

11.3.1.22 Slovakia: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.22.1 Slovakia: Gene Therapy Market Breakdown, by Product
11.3.1.22.2 Slovakia: Gene Therapy Market Breakdown, by Vector Type
11.3.1.22.3 Slovakia: Gene Therapy Market Breakdown, by Indication
11.3.1.22.4 Slovakia: Gene Therapy Market Breakdown, by End User

11.3.1.23 Bulgaria : Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.23.1 Bulgaria : Gene Therapy Market Breakdown, by Product
11.3.1.23.2 Bulgaria : Gene Therapy Market Breakdown, by Vector Type
11.3.1.23.3 Bulgaria : Gene Therapy Market Breakdown, by Indication
11.3.1.23.4 Bulgaria : Gene Therapy Market Breakdown, by End User

11.4 Asia-Pacific

11.4.1 Gene Therapy Market Breakdown, by Key Country, 2026 and 2033 (%)
11.4.1.1 Gene Therapy Market – Revenue and Forecast Analysis – by Country
11.4.1.1 China: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.1.1 China: Gene Therapy Market Breakdown, by Product
11.4.1.1.2 China: Gene Therapy Market Breakdown, by Vector Type
11.4.1.1.3 China: Gene Therapy Market Breakdown, by Indication
11.4.1.1.4 China: Gene Therapy Market Breakdown, by End User

11.4.1.2 Japan: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.2.1 Japan: Gene Therapy Market Breakdown, by Product
11.4.1.2.2 Japan: Gene Therapy Market Breakdown, by Vector Type
11.4.1.2.3 Japan: Gene Therapy Market Breakdown, by Indication
11.4.1.2.4 Japan: Gene Therapy Market Breakdown, by End User

11.4.1.3 South Korea: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.3.1 South Korea: Gene Therapy Market Breakdown, by Product
11.4.1.3.2 South Korea: Gene Therapy Market Breakdown, by Vector Type
11.4.1.3.3 South Korea: Gene Therapy Market Breakdown, by Indication
11.4.1.3.4 South Korea: Gene Therapy Market Breakdown, by End User

11.4.1.4 India: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.4.1 India: Gene Therapy Market Breakdown, by Product
11.4.1.4.2 India: Gene Therapy Market Breakdown, by Vector Type
11.4.1.4.3 India: Gene Therapy Market Breakdown, by Indication
11.4.1.4.4 India: Gene Therapy Market Breakdown, by End User

11.4.1.5 Australia: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.5.1 Australia: Gene Therapy Market Breakdown, by Product
11.4.1.5.2 Australia: Gene Therapy Market Breakdown, by Vector Type
11.4.1.5.3 Australia: Gene Therapy Market Breakdown, by Indication
11.4.1.5.4 Australia: Gene Therapy Market Breakdown, by End User

11.4.1.6 New Zealand: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.6.1 New Zealand: Gene Therapy Market Breakdown, by Product
11.4.1.6.2 New Zealand: Gene Therapy Market Breakdown, by Vector Type
11.4.1.6.3 New Zealand: Gene Therapy Market Breakdown, by Indication
11.4.1.6.4 New Zealand: Gene Therapy Market Breakdown, by End User

11.4.1.7 Indonesia: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.7.1 Indonesia: Gene Therapy Market Breakdown, by Product
11.4.1.7.2 Indonesia: Gene Therapy Market Breakdown, by Vector Type
11.4.1.7.3 Indonesia: Gene Therapy Market Breakdown, by Indication
11.4.1.7.4 Indonesia: Gene Therapy Market Breakdown, by End User

11.4.1.8 Malaysia: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.8.1 Malaysia: Gene Therapy Market Breakdown, by Product
11.4.1.8.2 Malaysia: Gene Therapy Market Breakdown, by Vector Type
11.4.1.8.3 Malaysia: Gene Therapy Market Breakdown, by Indication
11.4.1.8.4 Malaysia: Gene Therapy Market Breakdown, by End User

11.4.1.9 Philippines: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.9.1 Philippines: Gene Therapy Market Breakdown, by Product
11.4.1.9.2 Philippines: Gene Therapy Market Breakdown, by Vector Type
11.4.1.9.3 Philippines: Gene Therapy Market Breakdown, by Indication
11.4.1.9.4 Philippines: Gene Therapy Market Breakdown, by End User

11.4.1.10 Singapore: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.10.1 Singapore: Gene Therapy Market Breakdown, by Product
11.4.1.10.2 Singapore: Gene Therapy Market Breakdown, by Vector Type
11.4.1.10.3 Singapore: Gene Therapy Market Breakdown, by Indication
11.4.1.10.4 Singapore: Gene Therapy Market Breakdown, by End User

11.4.1.11 Thailand: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.11.1 Thailand: Gene Therapy Market Breakdown, by Product
11.4.1.11.2 Thailand: Gene Therapy Market Breakdown, by Vector Type
11.4.1.11.3 Thailand: Gene Therapy Market Breakdown, by Indication
11.4.1.11.4 Thailand: Gene Therapy Market Breakdown, by End User

11.4.1.12 Vietnam: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.12.1 Vietnam: Gene Therapy Market Breakdown, by Product
11.4.1.12.2 Vietnam: Gene Therapy Market Breakdown, by Vector Type
11.4.1.12.3 Vietnam: Gene Therapy Market Breakdown, by Indication
11.4.1.12.4 Vietnam: Gene Therapy Market Breakdown, by End User

11.4.1.13 Taiwan: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.13.1 Taiwan: Gene Therapy Market Breakdown, by Product
11.4.1.13.2 Taiwan: Gene Therapy Market Breakdown, by Vector Type
11.4.1.13.3 Taiwan: Gene Therapy Market Breakdown, by Indication
11.4.1.13.4 Taiwan: Gene Therapy Market Breakdown, by End User

11.4.1.14 Bangladesh : Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.14.1 Bangladesh : Gene Therapy Market Breakdown, by Product
11.4.1.14.2 Bangladesh : Gene Therapy Market Breakdown, by Vector Type
11.4.1.14.3 Bangladesh : Gene Therapy Market Breakdown, by Indication
11.4.1.14.4 Bangladesh : Gene Therapy Market Breakdown, by End User

11.5 South and Central America

11.5.1 Gene Therapy Market Breakdown, by Key Country, 2026 and 2033 (%)
11.5.1.1 Gene Therapy Market – Revenue and Forecast Analysis – by Country
11.5.1.1 Brazil: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.1.1 Brazil: Gene Therapy Market Breakdown, by Product
11.5.1.1.2 Brazil: Gene Therapy Market Breakdown, by Vector Type
11.5.1.1.3 Brazil: Gene Therapy Market Breakdown, by Indication
11.5.1.1.4 Brazil: Gene Therapy Market Breakdown, by End User

11.5.1.2 Argentina: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.2.1 Argentina: Gene Therapy Market Breakdown, by Product
11.5.1.2.2 Argentina: Gene Therapy Market Breakdown, by Vector Type
11.5.1.2.3 Argentina: Gene Therapy Market Breakdown, by Indication
11.5.1.2.4 Argentina: Gene Therapy Market Breakdown, by End User

11.5.1.3 Chile: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.3.1 Chile: Gene Therapy Market Breakdown, by Product
11.5.1.3.2 Chile: Gene Therapy Market Breakdown, by Vector Type
11.5.1.3.3 Chile: Gene Therapy Market Breakdown, by Indication
11.5.1.3.4 Chile: Gene Therapy Market Breakdown, by End User

11.5.1.4 Colombia: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.4.1 Colombia: Gene Therapy Market Breakdown, by Product
11.5.1.4.2 Colombia: Gene Therapy Market Breakdown, by Vector Type
11.5.1.4.3 Colombia: Gene Therapy Market Breakdown, by Indication
11.5.1.4.4 Colombia: Gene Therapy Market Breakdown, by End User

11.5.1.5 Peru : Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.5.1 Peru : Gene Therapy Market Breakdown, by Product
11.5.1.5.2 Peru : Gene Therapy Market Breakdown, by Vector Type
11.5.1.5.3 Peru : Gene Therapy Market Breakdown, by Indication
11.5.1.5.4 Peru : Gene Therapy Market Breakdown, by End User

11.6 Middle East and Africa

11.6.1 Gene Therapy Market Breakdown, by Key Country, 2026 and 2033 (%)
11.6.1.1 Gene Therapy Market – Revenue and Forecast Analysis – by Country
11.6.1.1 Saudi Arabia: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.1.1 Saudi Arabia: Gene Therapy Market Breakdown, by Product
11.6.1.1.2 Saudi Arabia: Gene Therapy Market Breakdown, by Vector Type
11.6.1.1.3 Saudi Arabia: Gene Therapy Market Breakdown, by Indication
11.6.1.1.4 Saudi Arabia: Gene Therapy Market Breakdown, by End User

11.6.1.2 United Arab Emirates: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.2.1 United Arab Emirates: Gene Therapy Market Breakdown, by Product
11.6.1.2.2 United Arab Emirates: Gene Therapy Market Breakdown, by Vector Type
11.6.1.2.3 United Arab Emirates: Gene Therapy Market Breakdown, by Indication
11.6.1.2.4 United Arab Emirates: Gene Therapy Market Breakdown, by End User

11.6.1.3 Kuwait: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.3.1 Kuwait: Gene Therapy Market Breakdown, by Product
11.6.1.3.2 Kuwait: Gene Therapy Market Breakdown, by Vector Type
11.6.1.3.3 Kuwait: Gene Therapy Market Breakdown, by Indication
11.6.1.3.4 Kuwait: Gene Therapy Market Breakdown, by End User

11.6.1.4 Bahrain: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.4.1 Bahrain: Gene Therapy Market Breakdown, by Product
11.6.1.4.2 Bahrain: Gene Therapy Market Breakdown, by Vector Type
11.6.1.4.3 Bahrain: Gene Therapy Market Breakdown, by Indication
11.6.1.4.4 Bahrain: Gene Therapy Market Breakdown, by End User

11.6.1.5 Qatar: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.5.1 Qatar: Gene Therapy Market Breakdown, by Product
11.6.1.5.2 Qatar: Gene Therapy Market Breakdown, by Vector Type
11.6.1.5.3 Qatar: Gene Therapy Market Breakdown, by Indication
11.6.1.5.4 Qatar: Gene Therapy Market Breakdown, by End User

11.6.1.6 Oman: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.6.1 Oman: Gene Therapy Market Breakdown, by Product
11.6.1.6.2 Oman: Gene Therapy Market Breakdown, by Vector Type
11.6.1.6.3 Oman: Gene Therapy Market Breakdown, by Indication
11.6.1.6.4 Oman: Gene Therapy Market Breakdown, by End User

11.6.1.7 Turkiye: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.7.1 Turkiye: Gene Therapy Market Breakdown, by Product
11.6.1.7.2 Turkiye: Gene Therapy Market Breakdown, by Vector Type
11.6.1.7.3 Turkiye: Gene Therapy Market Breakdown, by Indication
11.6.1.7.4 Turkiye: Gene Therapy Market Breakdown, by End User

11.6.1.8 South Africa: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.8.1 South Africa: Gene Therapy Market Breakdown, by Product
11.6.1.8.2 South Africa: Gene Therapy Market Breakdown, by Vector Type
11.6.1.8.3 South Africa: Gene Therapy Market Breakdown, by Indication
11.6.1.8.4 South Africa: Gene Therapy Market Breakdown, by End User

11.6.1.9 Egypt: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.9.1 Egypt: Gene Therapy Market Breakdown, by Product
11.6.1.9.2 Egypt: Gene Therapy Market Breakdown, by Vector Type
11.6.1.9.3 Egypt: Gene Therapy Market Breakdown, by Indication
11.6.1.9.4 Egypt: Gene Therapy Market Breakdown, by End User

11.6.1.10 Nigeria: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.10.1 Nigeria: Gene Therapy Market Breakdown, by Product
11.6.1.10.2 Nigeria: Gene Therapy Market Breakdown, by Vector Type
11.6.1.10.3 Nigeria: Gene Therapy Market Breakdown, by Indication
11.6.1.10.4 Nigeria: Gene Therapy Market Breakdown, by End User

11.6.1.11 Algeria: Gene Therapy Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.11.1 Algeria: Gene Therapy Market Breakdown, by Product
11.6.1.11.2 Algeria: Gene Therapy Market Breakdown, by Vector Type
11.6.1.11.3 Algeria: Gene Therapy Market Breakdown, by Indication
11.6.1.11.4 Algeria: Gene Therapy Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Novartis AG

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 F. Hoffmann-La Roche Ltd.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 BioMarin Pharmaceutical Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 CSL

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Vertex Pharmaceuticals Incorporated

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Krystal Biotech, Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Rocket Pharmaceuticals, Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Dyno Therapeutics, Inc.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Sangamo Therapeutics, Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Orchard Therapeutics plc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Access the Full G Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization